| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Enteric Neuroscience Program, Gastroenterology Research Unit, and 2 Endocrine Research Unit, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905
Glucagon-like peptide-1 (GLP-1) relaxes the stomach during fasting but decreases hunger and food consumption and retards gastric emptying. The interrelationships between volume, emptying, and postprandial symptoms in response to GLP-1 are unclear. We performed, in healthy human volunteers, a placebo-controlled study of the effects of intravenous GLP-1 on gastric volume using 99mTc-single photon emission computed tomography imaging, gastric emptying of a nutrient liquid meal (Ensure) using scintigraphy, maximum tolerated volume (MTV) of Ensure, and postprandial symptoms 30 min after MTV. The role of vagal cholinergic function in the effects of GLP-1 was assessed by human pancreatic polypeptide (HPP) response to the Ensure meal. GLP-1 increased fasting and postprandial gastric volumes and retarded gastric emptying; MTV and postprandial symptoms were not different compared with controls. Effects on postprandial gastric function were associated with reduced postprandial HPP levels. GLP-1 does not induce postprandial symptoms despite significant inhibition of gastric emptying and vagal function; this may be partly explained by the increase in postprandial gastric volume.
accommodation; single photon emission computed tomography; vagus; satiation; diabetes
This article has been cited by other articles:
|
|
 |
|
  K. G. Kumar, L. O. Byerley, J. Volaufova, D. J. Drucker, G. A. Churchill, R. Li, B. York, A. Zuberi, and B. K. S. Richards Genetic variation in Glp1r expression influences the rate of gastric emptying in mice Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R362 - R371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Choi, J. Zhu, G. J. Stoltz, S. Vernino, M. Camilleri, J. H. Szurszewski, S. J. Gibbons, and G. Farrugia Determination of gastric emptying in nonobese diabetic mice Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1039 - G1045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Andrews, A. E. Bharucha, M. Camilleri, P. A. Low, B. Seide, D. Burton, K. Baxter, and A. R. Zinsmeister Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1359 - G1365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Goetze, A. Steingoetter, D. Menne, I. R. van der Voort, M. A. Kwiatek, P. Boesiger, D. Weishaupt, M. Thumshirn, M. Fried, and W. Schwizer The effect of macronutrients on gastric volume responses and gastric emptying in humans: a magnetic resonance imaging study Am J Physiol Gastrointest Liver Physiol, January 1, 2007; 292(1): G11 - G17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Chelikani, A. C. Haver, and R. D. Reidelberger Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2005; 288(6): R1695 - R1706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Uckaya, P Delagrange, A Chavanieu, G Grassy, M-F Berthault, A Ktorza, E Cerasi, G Leibowitz, and N Kaiser Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogue J. Endocrinol., March 1, 2005; 184(3): 505 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sarnelli, D. Sifrim, J. Janssens, and J. Tack Influence of sildenafil on gastric sensorimotor function in humans Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G988 - G992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Castillo, S. Delgado-Aros, M. Camilleri, D. Burton, D. Stephens, R. O'Connor-Semmes, A. Walker, A. Shachoy-Clark, and A. R. Zinsmeister Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers Am J Physiol Gastrointest Liver Physiol, August 1, 2004; 287(2): G363 - G369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. D'Alessio and T. P. Vahl Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E882 - E890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Bennink, B. D. van den Elzen, S. D. Kuiken, and G. E. Boeckxstaens Noninvasive Measurement of Gastric Accommodation by Means of Pertechnetate SPECT: Limiting Radiation Dose Without Losing Image Quality J. Nucl. Med., January 1, 2004; 45(1): 147 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B D J van den Elzen, R J Bennink, R E Wieringa, G N J Tytgat, and G E E Boeckxstaens Fundic accommodation assessed by SPECT scanning: comparison with the gastric barostat Gut, November 1, 2003; 52(11): 1548 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Delgado-Aros, H. J. Chial, M. Camilleri, L. A. Szarka, F. T. Weber, J. Jacob, I. Ferber, S. McKinzie, D. D. Burton, and A. R. Zinsmeister Effects of a kappa -opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G558 - G566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamamoto, T. Kishi, C. E. Lee, B. J. Choi, H. Fang, A. N. Hollenberg, D. J. Drucker, and J. K. Elmquist Glucagon-Like Peptide-1-Responsive Catecholamine Neurons in the Area Postrema Link Peripheral Glucagon-Like Peptide-1 with Central Autonomic Control Sites J. Neurosci., April 1, 2003; 23(7): 2939 - 2946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E P Bouras, S Delgado-Aros, M Camilleri, E J Castillo, D D Burton, G M Thomforde, and H J Chial SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication Gut, December 1, 2002; 51(6): 781 - 786. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
